Mr. Speaker, I have a question for my colleague about extended pharmaceutical patent protection.
He mentioned extensions of three or three and a half years. However, from what I understand, it is two years. I would like some clarification on that.
In the House of Commons on February 13th, 2017. See this statement in context.
Canada-European Union Comprehensive Economic and Trade Agreement Implementation ActGovernment Orders
February 13th, 2017 / 1:30 p.m.
Liberal
Frank Baylis Liberal Pierrefonds—Dollard, QC
Mr. Speaker, I have a question for my colleague about extended pharmaceutical patent protection.
He mentioned extensions of three or three and a half years. However, from what I understand, it is two years. I would like some clarification on that.
See context to find out what was said next.